HOME >> MEDICINE >> NEWS
VIRTUE clinical trial opens to primary immunodeficiency patients across the U.S.

KING OF PRUSSIA, PA-September 12, 2006. ZLB Behring has announced the launch of the VIRTUE Trial, a Phase IV clinical trial of the study medication Vivaglobin (Immune Globulin Subcutaneous, Human), the first and only U.S. Food and Drug Administration-approved subcutaneous immunoglobulin (Ig) treatment for patients with primary immunodeficiency (PI). VIRTUE [Vivaglobin Investigator Research Trial on Use and Experience], will evaluate patient satisfaction and annual rate of serious bacterial infection using Vivaglobin subcutaneous administration for one year after conversion from intravenous immunoglobulin therapy.

VIRTUE will enroll 100 PI patients at 50 sites across the country, making it the largest-ever trial of subcutaneous (i.e., under the skin) immunoglobulin therapy in the United States. Patients enrolled in the study will self-administer the study medication for one year. During the trial period, patients will be asked to assess overall health-related quality of life, comparing experience receiving the study medication and their previous intravenous treatment experience. Additionally, VIRTUE will identify which patients are more inclined to use SC treatment because of the improvement in their quality of life.

"Being able to self-administer Vivaglobin at home will add a great deal of flexibility and convenience to the lives of many patients who wont have to go to the doctors office any longer to receive their therapy," said Dr. Melvin Berger, Professor of Pediatrics and Pathology at Case Western Reserve University and one of the lead researchers for the trial. "Some patients suffering from PI may not be able to use IVIg because of poor venous access, intolerability or severe adverse effects. Other patients may be too busy or cannot afford to take the time off from work or school to get to an infusion center every three or four weeks. SC, or subcutaneous treatment, may benefit these patients."

The study medication, Vivaglobin,
'"/>

Contact: Sheila Burke
Sheila.Burke@zlbbehring.com
610-878-4209
ZLB Behring
13-Sep-2006


Page: 1 2

Related medicine news :

1. New contracts support clinical trials on antibiotic-resistant, community-acquired staph infections
2. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
3. International journal group updates guidelines on registration of clinical trials
4. Urgent need for guidance on mobile phone use in clinical care
5. New prostate cancer clinical guidelines to be released
6. First clinical trial of gene therapy for childhood blindness
7. Acute coronary syndrome therapy improvements linked with fewer deaths and improved clinical outcomes
8. Taking the wraps off drug safety data from clinical trials
9. Preclinical results of Geovaxs AIDS vaccines demonstrate potential to protect against disease
10. 30+ AIDS vaccine clinical trials in 24 countries, research occurring on every continent
11. NIH-funded program co-directed by Mailman School of PH faculty to expedite clinical research process

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2020)... Ill. (PRWEB) , ... March 30, 2020 , ... ... name as the coronavirus pandemic sweeps the country. In an effort to keep ... software solutions are enabling police interaction with community members while minimizing direct contact. ...
(Date:3/28/2020)... ... March 27, 2020 , ... ... life as COVID-19 cases grow by the day, people of all ages are ... disorders—who have difficulties with social interactions in the best of times—the physical distance ...
(Date:3/28/2020)... ... 27, 2020 , ... To help prevent the spread of ... an alternative approach to seeing their patients. This approach will allow patients to ... own home or office using video conference and telecommunications technology, such as a ...
(Date:3/28/2020)... CINCINNATI (PRWEB) , ... March 28, 2020 , ... ... revenue cycle management services, integrated practice management, and patient engagement solutions has expanded ... coronavirus outbreak. , In this time of crisis, telemedicine has a big ...
(Date:3/27/2020)... PLAINS, N.J. (PRWEB) , ... March 27, 2020 ... ... has been reviewed and approved by NJ Top Docs. Dr. Kubeck has been ... American Board of Orthopaedic Surgery and specializes in Spinal Surgery. , Dr. ...
Breaking Medicine News(10 mins):
(Date:4/7/2020)... ... 07, 2020 , ... West Boca Eye Center Adapts to COVID-19 Pandemic Protocols ... providers are adopting radical precautions while treating patients. In accordance with the CDC and ... urgent or emergency nature. Brent Bellotte MD. explains how they’re providing for the welfare ...
(Date:4/5/2020)... ... April 04, 2020 , ... This week, the Arizona-based ... initiative, tasking ambassadors, support group leaders, board members and staff with calling hundreds ... with a movement disorder can be so isolating and PMD Alliance remains committed ...
(Date:4/5/2020)... ... April 04, 2020 , ... As the world ... medical supplies, diagnostics, and treatments. Shortages of such supplies are plaguing hospitals and ... , Tran & Associates supports the fight against COVID-19 and encourages every-day citizens ...
Breaking Medicine Technology:
Cached News: